Abstract

The transcription factor GLI1 (GLI family zinc finger 1) plays a key role in the development and progression of multiple malignancies. To date, regulation of transcriptional activity at target gene promoters is the only molecular event known to underlie the oncogenic function of GLI1. Here, we provide evidence that GLI1 controls chromatin accessibility at distal regulatory regions by modulating the recruitment of SMARCA2 (SWI/SNF-related, matrix-associated, actin-dependent regulator of chromatin, subfamily A, member 2) to these elements. We demonstrate that SMARCA2 endogenously interacts with GLI1 and enhances its transcriptional activity. Mapping experiments indicated that the C-terminal transcriptional activation domain of GLI1 and SMARCA2's central domains, including its ATPase motif, are required for this interaction. Interestingly, similar to SMARCA2, GLI1 overexpression increased chromatin accessibility, as indicated by results of the micrococcal nuclease assay. Further, results of assays for transposase-accessible chromatin with sequencing (ATAC-seq) after GLI1 knockdown supported these findings, revealing that GLI1 regulates chromatin accessibility at several regions distal to gene promoters. Integrated RNA-seq and ATAC-seq data analyses identified a subset of differentially expressed genes located in cis to these regulated chromatin sites. Finally, using the GLI1-regulated gene HHIP (Hedgehog-interacting protein) as a model, we demonstrate that GLI1 and SMARCA2 co-occupy a distal chromatin peak and that SMARCA2 recruitment to this HHIP putative enhancer requires intact GLI1. These findings provide insights into how GLI1 controls gene expression in cancer cells and may inform approaches targeting this oncogenic transcription factor to manage malignancies.

Highlights

  • The glioma-associated oncogene GLI1 was first identified in malignant glioma as a gene duplication [1]

  • Reporter assays in RMS13 and PANC-1 cells transiently transfected to express both the UAS reporter and GLI1– peptide/Gal4–DBD chimeric proteins demonstrated that transcriptional activity of GLI1 is found in its transactivation domain (TAD) and within TAD subdomains (Fig. 1C and Fig. S1A)

  • We investigated the association between GLI1 regulation of gene expression and chromatin accessibility modulated by GLI1 and SMARCA2 depletion

Read more

Summary

Introduction

The glioma-associated oncogene GLI1 was first identified in malignant glioma as a gene duplication [1]. These results point to a transcription regulation mechanism in which GLI1 and SMARCA2 cooperatively alter chromatin accessibility at sites located distally to target genes. GLI1 and SMARCA2 regulate chromatin accessibility at distal regions to gene transcription start sites

Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call